Book contents
- Androgens in Gynecological Practice
- Androgens in Gynecological Practice
- Copyright page
- Contents
- About the editors
- Dedication
- Contributors
- Preface
- Section 1 Managing the basics
- Section 2 The scientific essentials
- Section 3 Learning from the extremes
- Section 4 The tool kit
- 16 History and physical examination of polycystic ovary syndrome: Detecting too much or too little
- 17 Androgen assays: of mice and men
- 18 Magnetic resonance imaging of the adrenal gland
- 19 Androgens and DHEA in postmenopausal medicine
- 20 Lifestyle, diet, and exercise in polycystic ovary syndrome
- 21 Polycystic ovary syndrome ovulation induction
- 22 Ovulation induction in women with polycystic ovary syndrome
- Index
- Plate Section
- References
17 - Androgen assays: of mice and men
from Section 4 - The tool kit
Published online by Cambridge University Press: 05 July 2015
Book contents
- Androgens in Gynecological Practice
- Androgens in Gynecological Practice
- Copyright page
- Contents
- About the editors
- Dedication
- Contributors
- Preface
- Section 1 Managing the basics
- Section 2 The scientific essentials
- Section 3 Learning from the extremes
- Section 4 The tool kit
- 16 History and physical examination of polycystic ovary syndrome: Detecting too much or too little
- 17 Androgen assays: of mice and men
- 18 Magnetic resonance imaging of the adrenal gland
- 19 Androgens and DHEA in postmenopausal medicine
- 20 Lifestyle, diet, and exercise in polycystic ovary syndrome
- 21 Polycystic ovary syndrome ovulation induction
- 22 Ovulation induction in women with polycystic ovary syndrome
- Index
- Plate Section
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Androgens in Gynecological Practice , pp. 180 - 190Publisher: Cambridge University PressPrint publication year: 2015
References
1.McDonough, PG. Amount of error in a measurement?…Reliability. Fertil Steril 2003;80:1287–1288.CrossRefGoogle Scholar
2.Rosenfield, R. Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28:265–293.Google Scholar
3.Deslypere, JP, Young, M, Wilson, JD, et al. Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT report gene. Mol Cell Endocrinol 1992;88:15–22.Google Scholar
4.Arlt, W, Callies, F, van Vliimen, JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341:1013–1020.CrossRefGoogle ScholarPubMed
5.Burger, HG. Androgen production in women. Fertil Steril 1002;77 (suppl 4):S3–5.CrossRefGoogle Scholar
6.Pardridge, WM. Plasma protein–mediated transport of steroid and thyroid hormones. Am J Physiol 1987;252:E157–164.Google Scholar
7.Rosner, W, Hryb, DJ, Khan, MS, et al. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J Steroid Biochem Mol Biol 1991; 869:481–485.Google Scholar
8.Frank, RT, Klempner, E, Hollander, F, Kriss, B. Detailed description of technique for androgen assay by the chick comb method. Endocrinology 1942;31:63–70.Google Scholar
9.Hershberger, LG, Shipley, EG, Meyer, RK. Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Exp Biol Med 1953;83:175–180.Google Scholar
10.Yalow, RS, Berson, SA. Immunoassay of endogenous plasma insulin. J Clin Invest 1960;39:1157–1175.Google Scholar
11.Kasahara, Y. Homogeneous enzyme immunoassays. In: Nakamura, RM, Kasahara, Y, Rechnitz, GA (Eds.). Immunochemical Assays and Biosensor Technology for the 1990s. Washington, DC: American Society for Microbiology; 1992:169–182.Google Scholar
12.Ekins, RP. The estimation of thyroxine in human plasma by an electrophoretic technique. Clin Chim Acta 1960;5:453–459.Google Scholar
13.Singh, RJ. Validation of a high throughput method for serum/plasma testosterone using liquid chromatography tandem mass spectrometry (LC-MS/MS). Steroids 2008;73:1339–1344.Google Scholar
14.Hartig, PC, Bobseine, KL, Britt, BH, et al. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening. Toxicol Sci 2002; 66:82–90.Google Scholar
15.Lambright, C, Ostby, J, Bobseine, K, et al. Cellular and molecular mechanisms of action of linuron: an antiandrogenic herbicide that produces reproductive malformations in male rats. Toxicol Sci 2000;56:389–399.Google Scholar
16.Soto, AM, Maffini, MV, Schaeberle, CM, Sonnenschein, C. Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity. Best Pract Res Clin Endocrinol Metab 2006;20:15–33.CrossRefGoogle ScholarPubMed
17.Dobs, AS. The role of accurate testosterone testing in the treatment and management of male hypogonadism. Steroids 2008;73:1305–1310.Google Scholar
18.Bhasin, S, Zhang, A, Caviello, A, et al. The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders. Steroids 2008;73:1311–1317.Google Scholar
19.Rosner, W, Auchus, RJ, Azziz, R, et al. Position Statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:405–413.Google Scholar
20.Dorgan, JF, Fears, TR, McMahon, RP, et al. Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 2002;67:151–158.Google Scholar
21.Vermeulen, A, Verdonck, L, Kaufman, JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–3672.Google Scholar
22.Rosner, W. An extraordinary inaccurate assay for free testosterone is still with us. J Clin Endocrinol Metab 2001;86:2903.Google Scholar
23.Wheeler, MJ. The determination of bioavailable testosterone. Ann Clin Biochem 1995;32:345–357.Google Scholar
24.Morley, JE, Patrick, P, Perry, HM 3d. Evaluation of assays available to measure free testosterone. Metabolism 2002;51:554–559.Google Scholar
25.Elmlinger, MW, Kuhnel, W, Ranke, MB. Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and young adults. Clin Chem Lab Med 2005;40:1151–1160.Google Scholar
26.Wilde, C. Subject preparation, sample collection and handling. In: Wild, D. The Immunoassay Handbook. San Diego, CA: Elsevier, Inc; 2005: 443.Google Scholar
27.Davies, PH, Franklyn, JA. The effects of drugs on tests of thyroid function. Eur J Clin Pharmacol 1991;40:439–451.CrossRefGoogle Scholar
28.Warner, A. Interference of common household chemicals in immunoassay methods for drugs of abuse. Clin Chem 1989;35:648–651.CrossRefGoogle ScholarPubMed
29.Kato, K, Umeda, Y, Suzuki, F, Kosaka, A. Improved reaction buffers for solid-phase enzyme immunoassay without interference by serum factors. Clin Chim Acta 1980;102:261–265.Google Scholar
30.Shirtcliff, EA, Grander, DA, Schwartz, E, Curran, MJ. Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results. Psychoneuroendocrinology 2001;26:165–173.Google Scholar
31.Bowen, RAR, Chan, Y, Ruddel, ME, et al. Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant Silwet L-720. Clin Chem 2005;51:1874–1882.Google Scholar
32.Wenk, RE. Mechanism of interference by hemolysis in immunoassays and requirements for sample quality. Clin Chem 1998;44:2554.Google Scholar
33.Sapin, R, Gasser, F, Schlienger, JL. Familial dysalbuminemic hyperthyroxinemia and thyroid hormone autoantibodies: interference in current free thyroid hormone assays. Horm Res 1996;45:139–141.CrossRefGoogle ScholarPubMed
34.Wood, WG. “Matrix Effects” in immunoassays. Scand J Clin Lab Invest 1991;51:105–112.Google Scholar
35.Miller, JJ, Valdes, R Jr. Approaches to minimizing interference by cross-reacting molecules in immunoassays. Clin Chem 1991;37:144–153.Google Scholar
36.Miller, JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 2002;325:1–15.Google Scholar
37.Ramaeker, D, Brannian, J, Egland, K, et al. When is elevated testosterone not testosterone? When it is an immunoassay interfering antibody. Fertil Steril 2008;90:886–888.CrossRefGoogle Scholar
39.Spencer, CA. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. JCEM 2004;29:3702–3704.Google Scholar
40.Smith, TP, Suliman, AM, Fahie-Wilson, MN, McKenna, TJ. Gross variability in the detection of prolactin in sera containing big prolactin (Maroprolactin) by commercial immunoassays. JCEM 2002;87:5410–5415.CrossRefGoogle ScholarPubMed
41.Despres, N, Grant, AM. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem 1998;44:440–454.CrossRefGoogle ScholarPubMed
42.Fernando, SA, Wilson, GS. Studies of the ‘hook’ effect in the one-step sandwich immunoassay. J Immunol Methods 1992;151:47–66.Google Scholar
43.Emerson, JF, Ngo, G, Emerson, SS. Screening for interference in immunoassays. Clin Chem 2003;49:1163–1169.Google Scholar
44.Andersen, L, Jørgensen, PN, Jensen, LB, Walsh, D. A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies. Clin Biochem 2000;33:627–633.Google Scholar
45.Kricka, LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942–956.Google Scholar
46.Olsen, TG, Hubert, PR, Nycum, LR. Falsely elevated human chorionic gonadotropin leading to unnecessary therapy. Obstet Gynecol 2001;98:843–845.Google Scholar
47.Bjerner, J, Bormer, CP, Nustad, K. The war on heterophilic antibody interference. Clin Chem 2005;51:9–11.Google Scholar